Skip to main content

Clinical Pharmacokinetics

Ausgabe 4/2018

Inhalt (9 Artikel)

Leading Article

Key Pharmacokinetic Essentials of Fixed-Dosed Combination Products: Case Studies and Perspectives

Ranjeet Prasad Dash, Rana Rais, Nuggehally R. Srinivas

Review Article

PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer

Jill J. J. Geenen, Sabine C. Linn, Jos H. Beijnen, Jan H. M. Schellens

Open Access Original Research Article

A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation

Louise M. Andrews, Dennis A. Hesselink, Teun van Gelder, Birgit C. P. Koch, Elisabeth A. M. Cornelissen, Roger J. M. Brüggemann, Ron H. N. van Schaik, Saskia N. de Wildt, Karlien Cransberg, Brenda C. M. de Winter

Original Research Article

Prediction of the Effect of Renal Impairment on the Pharmacokinetics of New Drugs

Elisa Borella, Italo Poggesi, Paolo Magni

Original Research Article

Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults

Johanna Melin, Zinnia P. Parra-Guillen, Niklas Hartung, Wilhelm Huisinga, Richard J. Ross, Martin J. Whitaker, Charlotte Kloft

Open Access Original Research Article

Influence of Disease and Patient Characteristics on Daratumumab Exposure and Clinical Outcomes in Relapsed or Refractory Multiple Myeloma

Xiaoyu Yan, Pamela L. Clemens, Thomas Puchalski, Sagar Lonial, Henk Lokhorst, Peter M. Voorhees, Saad Usmani, Paul G. Richardson, Torben Plesner, Kevin Liu, Robert Z. Orlowski, Nedjad Losic, Richard Jansson, Tahamtan Ahmadi, Kristen Lantz, Juan Jose Perez Ruixo, Honghui Zhou, Xu Steven Xu